HIV+ MALT lymphoma remission induced by highly active antiretroviral therapy alone

Eur J Haematol. 2005 Jan;74(1):70-2. doi: 10.1111/j.1600-0609.2004.00339.x.

Abstract

MALT lymphoma is usually described in association with Helicobacter pylori, HCV, HHV8, Campylobacter jejuni or in a setting of overreactive immunity. In HIV(+) patients, MALT lymphoma is most commonly described in children. We describe here an original case of HIV(+) MALT lymphoma with bronchial, conjuctival and laryngeal involvement for which a clinical and histopathological remission has been obtained with HAART alone. We conclude that HIV, as well as H. pylori, C. jejuni and HCV can target lymphogenesis in MALT lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Antiretroviral Therapy, Highly Active*
  • Female
  • Gene Rearrangement, B-Lymphocyte
  • Humans
  • Lymphoma, AIDS-Related / drug therapy*
  • Lymphoma, AIDS-Related / genetics
  • Lymphoma, AIDS-Related / immunology
  • Lymphoma, AIDS-Related / pathology
  • Lymphoma, B-Cell, Marginal Zone / complications*
  • Lymphoma, B-Cell, Marginal Zone / drug therapy*
  • Lymphoma, B-Cell, Marginal Zone / immunology
  • Lymphoma, B-Cell, Marginal Zone / pathology
  • Middle Aged
  • Remission Induction